Sources | Names Used |
---|---|
CCLE, CTRPv2 | L-685458 |
PharmacoGx | L-685458 |
Database | Identifier |
---|---|
Smiles: | CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OC(C)(C)C)O |
Inchikey: | MURCDOXDAHPNRQ-ZJKZPDEISA-N |
Pubchem: | 5479543 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TET3 | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
mRNA | VCX2 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | PTBP3 | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
mRNA | C16orf54 | CCLE | pan-cancer | AAC | 0.23 | 6e-05 |
mRNA | HRH4 | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
mRNA | BACH2 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | DRAXIN | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
mRNA | RP13-347D8.7 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | NAT6 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
mRNA | NOX1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |